These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22824638)

  • 1. Brown-Vialetto-van Laere and Fazio-Londe overlap syndromes: a clinical, biochemical and genetic study.
    Ciccolella M; Catteruccia M; Benedetti S; Moroni I; Uziel G; Pantaleoni C; Chiapparini L; Bizzi A; D'Amico A; Fattori F; Salsano ML; Pastore A; Tozzi G; Piemonte F; Bertini E
    Neuromuscul Disord; 2012 Dec; 22(12):1075-82. PubMed ID: 22824638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brown-Vialetto-Van Laere syndrome: a riboflavin-unresponsive patient with a novel mutation in the C20orf54 gene.
    Koy A; Pillekamp F; Hoehn T; Waterham H; Klee D; Mayatepek E; Assmann B
    Pediatr Neurol; 2012 Jun; 46(6):407-9. PubMed ID: 22633641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brown-Vialetto-van Laere syndrome: a riboflavin responsive neuronopathy of infancy with singular features.
    Spagnoli C; Pitt MC; Rahman S; de Sousa C
    Eur J Paediatr Neurol; 2014 Mar; 18(2):231-4. PubMed ID: 24206674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives.
    Bosch AM; Stroek K; Abeling NG; Waterham HR; Ijlst L; Wanders RJ
    Orphanet J Rare Dis; 2012 Oct; 7():83. PubMed ID: 23107375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riboflavin transporter 3 involvement in infantile Brown-Vialetto-Van Laere disease: two novel mutations.
    Ciccolella M; Corti S; Catteruccia M; Petrini S; Tozzi G; Rizza T; Carrozzo R; Nizzardo M; Bordoni A; Ronchi D; D'Amico A; Rizzo C; Comi GP; Bertini E
    J Med Genet; 2013 Feb; 50(2):104-7. PubMed ID: 23243084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment.
    Bosch AM; Abeling NG; Ijlst L; Knoester H; van der Pol WL; Stroomer AE; Wanders RJ; Visser G; Wijburg FA; Duran M; Waterham HR
    J Inherit Metab Dis; 2011 Feb; 34(1):159-64. PubMed ID: 21110228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of motor dysfunction in a childhood motor neuron disease caused by mutations in the riboflavin transporter.
    Menezes MP; Farrar MA; Webster R; Antony J; O'Brien K; Ouvrier R; Kiernan MC; Burns J; Vucic S
    Clin Neurophysiol; 2016 Jan; 127(1):911-918. PubMed ID: 26092362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brown-Vialetto-Van Laere Syndrome as a Mimic of Neuroimmune Disorders: 3 Cases From the Clinic and Review of the Literature.
    Allison T; Roncero I; Forsyth R; Coffman K; Pichon JL
    J Child Neurol; 2017 May; 32(6):528-532. PubMed ID: 28116953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case report of sudden-onset auditory neuropathy spectrum disorder associated with Brown-Vialetto-Van Laere syndrome (riboflavin transporter deficiency).
    Gedik Soyuyuce O; Ayanoglu Aksoy E; Yapici Z
    Int J Audiol; 2022 Mar; 61(3):258-264. PubMed ID: 33983862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brown-Vialetto-Van Laere syndrome: clinical and neuroradiological findings of a genetically proven patient.
    Bandettini Di Poggio M; Monti Bragadin M; Reni L; Doria-Lamba L; Cereda C; Pardini M; Roccatagliata L; Rossi A; Schenone A
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Mar; 15(1-2):141-4. PubMed ID: 24079556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case Report of Riboflavin Treatment and Cochlear Implants in a 4-Year-Old Girl with Progressive Hearing Loss and Delayed Speech Development: Brown-Vialetto-Van Laere Syndrome.
    Piecuch AK; Skarżyński PH; Skarżyński H
    Am J Case Rep; 2023 Oct; 24():e940439. PubMed ID: 37786244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Madras motor neuron disease (MMND) is distinct from the riboflavin transporter genetic defects that cause Brown-Vialetto-Van Laere syndrome.
    Nalini A; Pandraud A; Mok K; Houlden H
    J Neurol Sci; 2013 Nov; 334(1-2):119-22. PubMed ID: 24139842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auditory neuropathy in Brown-Vialetto-Van Laere syndrome due to riboflavin transporter RFVT2 deficiency.
    Menezes MP; O'Brien K; Hill M; Webster R; Antony J; Ouvrier R; Birman C; Gardner-Berry K
    Dev Med Child Neurol; 2016 Aug; 58(8):848-54. PubMed ID: 26918385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infantile progressive bulbar palsy with deafness.
    Voudris KA; Skardoutsou A; Vagiakou EA
    Brain Dev; 2002 Oct; 24(7):732-5. PubMed ID: 12427524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown-Vialetto disease that is partially rescued by riboflavin.
    Rizzo F; Ramirez A; Compagnucci C; Salani S; Melzi V; Bordoni A; Fortunato F; Niceforo A; Bresolin N; Comi GP; Bertini E; Nizzardo M; Corti S
    Sci Rep; 2017 Apr; 7():46271. PubMed ID: 28382968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2.
    Foley AR; Menezes MP; Pandraud A; Gonzalez MA; Al-Odaib A; Abrams AJ; Sugano K; Yonezawa A; Manzur AY; Burns J; Hughes I; McCullagh BG; Jungbluth H; Lim MJ; Lin JP; Megarbane A; Urtizberea JA; Shah AH; Antony J; Webster R; Broomfield A; Ng J; Mathew AA; O'Byrne JJ; Forman E; Scoto M; Prasad M; O'Brien K; Olpin S; Oppenheim M; Hargreaves I; Land JM; Wang MX; Carpenter K; Horvath R; Straub V; Lek M; Gold W; Farrell MO; Brandner S; Phadke R; Matsubara K; McGarvey ML; Scherer SS; Baxter PS; King MD; Clayton P; Rahman S; Reilly MM; Ouvrier RA; Christodoulou J; Züchner S; Muntoni F; Houlden H
    Brain; 2014 Jan; 137(Pt 1):44-56. PubMed ID: 24253200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early use of high-dose riboflavin in a case of Brown-Vialetto-Van Laere syndrome.
    Anand G; Hasan N; Jayapal S; Huma Z; Ali T; Hull J; Blair E; McShane T; Jayawant S
    Dev Med Child Neurol; 2012 Feb; 54(2):187-9. PubMed ID: 22098162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brown-Vialetto-Van Laere syndrome and Fazio-Londe disease - treatable motor neuron diseases of childhood.
    Spagnoli C; De Sousa C
    Dev Med Child Neurol; 2012 Apr; 54(4):292-3. PubMed ID: 22211384
    [No Abstract]   [Full Text] [Related]  

  • 19. Adult onset Brown-Vialetto-Van Laere syndrome with opsoclonus and a novel heterozygous mutation: a case report.
    Cosgrove J; Datta S; Busby M
    Clin Neurol Neurosurg; 2015 Jan; 128():1-3. PubMed ID: 25462087
    [No Abstract]   [Full Text] [Related]  

  • 20. Brown-Vialetto-Van Laere and Fazio Londe syndromes: defects of riboflavin transport with biochemical similarities to multiple acyl-CoA dehydrogenation defects (MADD).
    Bennett MJ
    J Inherit Metab Dis; 2012 Nov; 35(6):941-2. PubMed ID: 22976761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.